Insulin glargine and lixisenatide and Maxalt-MLT
Determining the interaction of Insulin glargine and lixisenatide and Maxalt-MLT and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin Glargine and Lixisenatide
Generic Name: rizatriptan
Brand name: Maxalt, Maxalt-MLT
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine and lixisenatide-Maxaquin
- Insulin glargine and lixisenatide-Maxaron Forte (Cyanocobalamin, Folic Acid, Iron, and Vitamin C)
- Insulin glargine and lixisenatide-Maxaron Forte (Iron/L-Methylfolate/Vitamin B12/Vitamin C)
- Insulin glargine and lixisenatide-Maxaron Forte Capsules
- Insulin glargine and lixisenatide-Maxichlor PEH DM
- Insulin glargine and lixisenatide-Maxichlor PSE DM
- Maxalt-MLT-Insulin glargine and lixisenatide Subcutaneous
- Maxalt-MLT-Insulin glargine, recombinant Subcutaneous
- Maxalt-MLT-Insulin glulisine
- Maxalt-MLT-Insulin Glulisine (Cartridges and Pens)
- Maxalt-MLT-Insulin Glulisine (Vials)
- Maxalt-MLT-Insulin glulisine Subcutaneous